GENOMICTREE

The current price of 228760 is 22950 KRW — it has decreased by 2.75% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOMICTREE stocks are traded under the ticker 228760.

228760 stock is 3.06% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is GENOMICTREE there?

Yes, you can track GENOMICTREE financials in yearly and quarterly reports right on TradingView.

228760 stock has risen by 5.52% compared to the previous week, the month change is a 0.66% rise, over the last year GENOMICTREE has showed a 86.59% increase.

228760 net income for the last quarter is ‪−1.40 B‬ KRW, while the quarter before that showed ‪−2.70 B‬ KRW of net income which accounts for 48.06% change. Track more GENOMICTREE financial stats to get the full picture.

No, 228760 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 228760 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMICTREE stock right from TradingView charts — choose your broker and connect to your account.

228760 reached its all-time high on May 13, 2019 with the price of 39700 KRW, and its all-time low was 8300 KRW and was reached on Oct 21, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 79.00 employees. See our rating of the largest employees — is GENOMICTREE on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMICTREE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMICTREE stock shows the buy signal. See more of GENOMICTREE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMICTREE EBITDA is ‪−16.19 B‬ KRW, and current EBITDA margin is −473.56%. See more stats in GENOMICTREE financial statements.